Cited by 414

The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.

Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 1. Receptor Interactions

Open access

Jordan, V. Craig·2003·Journal of Medicinal Chemistry

DOI 10.1021/jm020449y

Open this paper in CoChat — free account

Abstract

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTAntiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 1. Receptor InteractionsV. Craig JordanView Author Information Robert H. Lurie Comprehensive Cancer Center, The Feinberg School of Medicine of Northwestern University, 303 East Chicago Avenue, MS N505, Chicago, Illinois 60611 Cite this: J. Med. Chem. 2003, 46, 6, 883–908Publication Date (Web):February 25, 2003Publication History Received9 October 2002Published online25 February 2003Published inissue 1 March 2003https://doi.org/10.1021/jm020449yCopyright © 2003 American Chemical SocietyRequest reuse permissionsArticle Views2073Altmetric-Citations321LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (1 MB) Get e-AlertscloseSUBJECTS:Cancer,Ligands,Peptides and proteins,Receptors,Rodent models Get e-Alerts

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1021/jm020449y

Cites

264 of 264 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Items 201–264 of 264

Identification of a Third Autonomous Activation Domain within the Human Estrogen Receptor
Norris, J. D., Fan, D., Kerner, S. A., & McDonnell, D. P. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.6.0008 · Cited by 113
Induction of Ovulation with Clomiphene Citrate
Wallach, E. E., & Huppert, L. C. (1979) · Fertility and Sterility · doi:10.1016/s0015-0282(16)43749-0 · Cited by 111
Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
Schafer, J. M., Liu, H., Bentrem, D. J., Zapf, J. W., & Jordan, V. C. (2000) · PubMed · Cited by 110
Self-citation
Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha.
Vanacker, J.-M., Delmarre, C., Guo, X., & Laudet, V. (1998) · PubMed · Cited by 109
Two organochlorine pesticides, toxaphene and chlordane, are antagonists for estrogen-related receptor alpha-1 orphan receptor.
Yang, C., & Chen, S. (1999) · PubMed · Cited by 107
Antiestrogens: Mechanisms and actions in target cells
Katzenellenbogen, B. S., Montano, M. M., Goff, P. L., Schodin, D. J., Kraus, W. L., Bhardwaj, B., & Fujimoto, N. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00084-d · Cited by 107
Dual-energy X-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats
Sato, M., McClintock, C., Kim, J., Turner, C. H., Bryant, H. U., Magee, D. E., & Slemenda, C. W. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090517 · Cited by 103
Estrogen Receptor β Activates the Human Retinoic Acid Receptorα -1 Promoter in Response to Tamoxifen and Other Estrogen Receptor Antagonists, but Not in Response to Estrogen
Zou, A., Marschke, K. B., Arnold, K. E., Berger, E. M., Fitzgerald, P., Mais, D. E., & Allegretto, E. A. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.3.0253 · Cited by 103
THE INDUCTION OF OVULATION BY TAMOXIFEN
Williamson, J. G., & Ellis, J. D. (1973) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1973.tb11230.x · Cited by 103
Expression of the estrogen-related receptor 1 (ERR-1) orphan receptor during mouse development
Bonnelye, E., Vanacker, J. M., Spruyt, N., Alric, S., Fournier, B., Desbiens, X., & Laudet, V. (1997) · Mechanisms of Development · doi:10.1016/s0925-4773(97)00059-2 · Cited by 100
The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats
Gallagher, A. C., Chambers, T. J., & Tobias, J. H. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243306 · Cited by 100
A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction
Boostanfar, R., Jain, J. K., Mishell, D. R., & Paulson, R. J. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01749-6 · Cited by 97
An Isoform of the Coactivator AIB1 That Increases Hormone and Growth Factor Sensitivity Is Overexpressed in Breast Cancer
Reiter, R., Wellstein, A., & Riegel, A. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104744200 · Cited by 94
NECROPSY DIAGNOSIS OF ENDOMETRIAL CANCER AND DETECTION-BIAS IN CASE/CONTROL STUDIES
Horwitz, R. I., Horwitz, S. M., Feinstein, A., & Robboy, S. J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90412-8 · Cited by 93
Exploring the role of sex steroids through studies of receptor deficient mice
Couse, J. F., & Korach, K. S. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050244 · Cited by 92
Cloning, Sequencing, and Localization of Bovine Estrogen Receptor-β within the Ovarian Follicle1
Rosenfeld, C. S., Yuan, X., Manikkam, M., Calder, M. D., Garverick, H. A., & Lubahn, D. B. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.3.691 · Cited by 89
A Negative Coregulator for the Human ER
Norris, J. D., Fan, D., Sherk, A. B., & McDonnell, D. P. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.3.0787 · Cited by 89
Estrogen Receptor Domains E and F: Role in Dimerization and Interaction with Coactivator RIP-140
Peters, G. A., & Khan, S. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0244 · Cited by 88
The Receptor-associated Coactivator 3 Activates Transcription through CREB-binding Protein Recruitment and Autoregulation
Li, H., & Chen, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5948 · Cited by 87
Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus
Jordan, V. C., & Gosden, B. (1982) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(82)90095-8 · Cited by 86
Self-citation
Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
Murphy, C. S., Langan-Fahey, S. M., McCague, R., et al. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09527-6 · Cited by 85
A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog.
Catherino, W. H., Wolf, D. M., & Jordan, V. C. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.8.7476979 · Cited by 83
Self-citation
Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice
Wolf, D. M., & Jordan, V. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00689682 · Cited by 78
Self-citation
Interaction and Dissociation by Ligands of Estrogen Receptor and Hsp90: The Antiestrogen RU 58668 Induces a Protein Synthesis-Dependent Clustering of the Receptor in the Cytoplasm
Leclerc, J., Meng, X., Delahaye, F., Leclerc, P., Baulieu, É.-É., & CATELLI, M. G. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.6.0121 · Cited by 78
Estrogen receptor β is expressed in human colorectal adenocarcinoma
Witte, D. A., Chirala, M., Younes, A., Li, Y., & Younes, M. (2001) · Human Pathology · doi:10.1053/hupa.2001.27117 · Cited by 78
Different TBP-associated factors are required for mediating the stimulation of transcriptionin vitroby the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor
Brou, C., Jun, W., Ali, S., Scheer, E., Lang, C., Davidson, I., Chambon, P., & Tora, L. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.1.5 · Cited by 78
Antiestrogenic Action of Raloxifene and Tamoxifen: Today and Tomorrow
Jordan, V. C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.13.967 · Cited by 78
Self-citation
Effect of long-term tamoxifen therapy on cancellous bone remodeling and structure in women with breast cancer
Wright, C. D. P., Garrahan, N. J., Stanton, M., Gazet, J. C., Mansell, R., & Compston, J. E. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090204 · Cited by 76
Molecular Basis for the Constitutive Activity of Estrogen-related Receptor α-1
Chen, S., Zhou, D., Yang, C., & Sherman, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102638200 · Cited by 73
Evidence that the antiestrogen binding site is a histamine or histamine-like receptor
Brandes, L. J., Macdonald, L. M., & Bogdanovic, R. P. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90271-2 · Cited by 70
The interaction of raloxifene and the active metabolite of the antiestrogen EM-800 (SC 5705) with the human estrogen receptor.
Schafer, J. M., Liu, H., Tonetti, D. A., & Jordan, V. C. (1999) · PubMed · Cited by 65
Self-citation
Estrogen receptor α and estrogen receptor-related receptor α1 compete for binding and coactivator
Zhang, Z., & Teng, C. T. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00372-5 · Cited by 64
Effects of Raloxifene After Tamoxifen on Breast and Endometrial Tumor Growth in Athymic Mice
O'Regan, R. M., Gajdos, C., Dardes, R. C., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.274 · Cited by 64
Increased Therapeutic Index of Antineoplastic Drugs in Combination With Intracellular Histamine Antagonists
Brandes, L. J., LaBella, F. S., & Warrington, R. C. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.18.1329 · Cited by 60
Agonistic and Antagonistic Effects of Clomiphene Citrate and Its Isomers1
Clark, J. H., & Guthrie, S. C. (1981) · Biology of Reproduction · doi:10.1095/biolreprod25.3.667 · Cited by 58
Identification of two hERR2-related novel nuclear receptors utilizing bioinformatics and inverse PCR
Chen, F., Zhang, Q., McDonald, T., Davidoff, M. J., Bailey, W., Bai, C., Liu, Q., & Caskey, C. T. (1999) · Gene · doi:10.1016/s0378-1119(98)00619-2 · Cited by 58
Calmodulin Enhances the Stability of the Estrogen Receptor
Li, Z., Joyal, J. L., & Sacks, D. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010238200 · Cited by 56
A diphenylmethane derivative specific for the antiestrogen binding site found in rat liver microsomes
Brandes, L. J., & Hermonat, M. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)90289-4 · Cited by 55
Structure and expression of the human θl globin gene
Hsu, S., Marks, J., Shawt, J., Tam, M. F., Higgs, D. R., Shen, C. C., & Shen, C.-K. J. (1988) · Nature · doi:10.1038/331094a0 · Cited by 54
Constraints on the origin of the Moon's atmosphere from observations during a lunar eclipse
Mendillo, M. J., & Baumgardner, J. L. (1995) · Nature · doi:10.1038/377404a0 · Cited by 52
Ligand-Selective Interactions of ER Detected in Living Cells by Fluorescence Resonance Energy Transfer
Weatherman, R. V., Chang, C., Clegg, N. J., Carroll, D. C., Day, R. N., Baxter, J. D., McDonnell, D. P., Scanlan, T. S., & Schaufele, F. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.3.0813 · Cited by 51
Correction: A comparative embryological study of two ornithischian dinosaurs
Horner, J. R., & Weishampel, D. B. (1996) · Nature · doi:10.1038/383103b0 · Cited by 49
The short term effects of tamoxifen on bone turnover in older women
Kenny, R. A., Prestwood, K. M., Pilbeam, C. C., & Raisz, L. G. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593440 · Cited by 48
Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells
Tikkanen, M. K., Carter, D. J., Harris, A. M., Le, H. M., Azorsa, D. O., Meltzer, P. S., & Murdoch, F. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220427297 · Cited by 46
Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF)
Klinge, C. M. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00124-7 · Cited by 46
Ligand Interaction at the Estrogen Receptor to Program Antiestrogen Action: A Study With Nonsteroidal Compoundsin Vitro*
Jordan, V. C., Koch, R. J., Langan-Fahey, S. M., & McCague, R. (1988) · Endocrinology · doi:10.1210/endo-122-4-1449 · Cited by 46
Self-citation
Substituted Aminoalkoxytriarylhaloethylenes
Palopoli, F. P., Feil, V. J., Allen, R. E., Holtkamp, D. E., & Richardson, A. (1967) · Journal of Medicinal Chemistry · doi:10.1021/jm00313a017 · Cited by 41
Cell adhesion molecules
Murray, P. A., Frampton, G., & Nelson, P. (1999) · BMJ · doi:10.1136/bmj.319.7206.332 · Cited by 37
Human Estrogen Receptor-Like 1 (ESRL1) Gene: Genomic Organization, Chromosomal Localization, and Promoter Characterization
Shi, H., Shigeta, H., Yang, N., Fu, K., OBrian, G. R., & Teng, C. T. (1997) · Genomics · doi:10.1006/geno.1997.4850 · Cited by 36
N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancer.
Brandes, L. J., Bracken, S. P., & Ramsey, E. W. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1398 · Cited by 35
Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site
Briand‐Mésange, F., Sebbar, M., Kedjouar, B., Capdevielle, J., Guillemot, J.-C., Ferrara, P., Bayard, F., DELARUE, F., Faye, J., & Poirot, M. (1998) · Biochemical Journal · doi:10.1042/bj3340107 · Cited by 31
Vertebral Bone Mineral Density, Content and Area in 8789 Normal Women Aged 33-73 Years Who Have Never Had Hormone Replacement Therapy
Shipman, A. J., Guy, G. W., Smith, I., Ostlere, S., Greer, W., & Smith, R. (1999) · Osteoporosis International · doi:10.1007/s001980050166 · Cited by 29
Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression
Klinge, C. M. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00019-2 · Cited by 29
An Antiestrogen-responsive Estrogen Receptor-α Mutant (D351Y) Shows Weak AF-2 Activity in the Presence of Tamoxifen*
Webb, P., Nguyen, P., Valentine, C. D., Weatherman, R., Scanlan, T., & Kushner, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007435200 · Cited by 28
Estrogen, Selective Estrogen Receptor Modulation, and Coronary Heart Disease: Something or Nothing
Jordan, V. C. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.2 · Cited by 24
Self-citation
Identification of three new genes and estimation of the size of the carcinoembryonic antigen family
Khan, W. N., Frängsmyr, L., Teglund, S., Israelsson, A. C. E., Bremer, K., & Hammarström, S. (1992) · Genomics · doi:10.1016/s0888-7543(05)80230-7 · Cited by 23
Microsomal Epoxide Hydrolase Expression as a Predictor of Tamoxifen Response in Primary Breast Cancer: A Retrospective Exploratory Study With Long-Term Follow-Up
Fritz, P., Mürdter, T. E., Eichelbaum, M. F., Siegle, I., Weissert, M., & Zanger, U. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.3 · Cited by 22
Structural components necessary for the antiestrogenic activity of tamoxifen
Murphy, C. S., & Jordan, V. C. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90117-9 · Cited by 22
Self-citation
High-affinity binding sites for oxygenated sterols in rat liver microsomes: possible identity with antiestrogen binding sites☆
HWANG, P. (1990) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(90)90006-i · Cited by 20
The intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine.HCl, may potentiate doxorubicin in the treatment of metastatic breast cancer: Results of a pilot study
Brandes, L. J., & Bracken, S. P. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005909808529 · Cited by 18
Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity
Delarue, F., Kedjouar, B., Briand‐Mésange, F., Bayard, F., Faye, J., & Poirot, M. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00347-5 · Cited by 18
Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sites.
Jones, J. A., Albright, K. D., Christen, R. D., Howell, S. B., & McClay, E. F. (1997) · PubMed · Cited by 17
A potent and selective photoaffinity probe for the anti-estrogen binding site of rat liver.
Poirot, M., Chailleux, C., Fargin, A., Bayard, F., & Faye, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44865-4 · Cited by 17
Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(20000501)88:9

Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential
Paterni, I., Granchi, C., Katzenellenbogen, J. A., & Minutolo, F. (2014) · Steroids · doi:10.1016/j.steroids.2014.06.012 · Cited by 721
Structural Overview of the Nuclear Receptor Superfamily: Insights into Physiology and Therapeutics
Huang, P., Chandra, V., & Rastinejad, F. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135917 · Cited by 533
Resveratrol as an anticancer nutrient: molecular basis, open questions and promises
Signorelli, P., & Ghidoni, R. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.01.017 · Cited by 489
Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
Chwalisz, K., Perez, M. C., DeManno, D., Winkel, C., Schubert, G., & Elger, W. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0001 · Cited by 310
Probing Protein Ligand Interactions by Automated Hydrogen/Deuterium Exchange Mass Spectrometry
Chalmers, M. J., Busby, S. A., Pascal, B. D., He, Y., Hendrickson, C. L., Marshall, A. G., & Griffin, P. R. (2006) · Analytical Chemistry · doi:10.1021/ac051294f · Cited by 301

See all 414

Authors: Jordan, V. C.
Venue: Journal of Medicinal Chemistry
Publisher: American Chemical Society (ACS)
Published: 2003-02-25
Volume: 46
Issue: 6
Pages: 883-908
ISSN: 0022-2623 (ISSN-L)
1520-4804
DOI: 10.1021/jm020449y
OpenAlex: W2098010773
Cited by: 414
References: 264
FWCI: 19.26
Type: journal article
Language: en
Open access: green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 1. Receptor Interactions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources